• Can we Promote Liver Regeneration in Patients with Decompensated Cirrhosis?

Can we Promote Liver Regeneration in Patients with Decompensated Cirrhosis?

The combination of granulocyte colony-stimulating factor (G-CSF) and a long-acting form of erythropoietin increases survival of patients with decompensated cirrhosis, researchers report in the June issue of Gastroenterology. The growth factor combination also improved liver function and reduced risk for septic shock within 1 y of treatment. Decompensation in patients

Read more